Christopher C. Nixon

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 319 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

Michael J. Peluso, Amelia N. Deitchman, Leonel Torres et al. · Cell Reports · 2021 · 267 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment

Cari F. Kessing, Christopher C. Nixon, Chuan Li et al. · Cell Reports · 2017 · 258 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

Bing Sun, Norina Tang, Michael J. Peluso et al. · Cells · 2021 · 187 citations · Full text

Life Sciences, Infectious Diseases, Neurobiology +17

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Michael J. Peluso, Saki Takahashi, Jill Hakim et al. · Science Advances · 2021 · 150 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16